2022 Q3 Form 10-Q Financial Statement

#000168316822005953 Filed on August 22, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.00 $260.00 $40.00
YoY Change -99.12%
Cash & Equivalents $6.00 $262.00 $40.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $38.22K
Other Receivables $0.00
Total Short-Term Assets $38.22K $262.00 $40.00
YoY Change 3252.98%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $38.22K $262.00 $40.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $38.22K $262.00 $40.00
YoY Change 3252.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $114.0K $92.85K $89.90K
YoY Change 931.58%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $114.0K $92.85K $89.90K
YoY Change 931.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $114.0K $92.85K $89.90K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $114.0K $92.85K $89.90K
YoY Change 931.59%
SHAREHOLDERS EQUITY
Retained Earnings -$6.288M -$2.556M
YoY Change
Common Stock $466.8K $296.7K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$75.77K -$92.59K -$89.86K
YoY Change
Total Liabilities & Shareholders Equity $38.22K $262.00 $40.00
YoY Change 3252.98%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001411165
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56362
dei Entity Registrant Name
EntityRegistrantName
EVER HARVEST INTERNATIONAL GROUP INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-1282601
dei Entity Address Address Line1
EntityAddressAddressLine1
Suite F, 16/F, Cameron Plaza
dei Entity Address Address Line2
EntityAddressAddressLine2
23 Cameron Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Tsim Sha Tsui
dei Entity Address Country
EntityAddressCountry
HK
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
00000
dei City Area Code
CityAreaCode
852
dei Local Phone Number
LocalPhoneNumber
2732 0018
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
296748183 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
262 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7504 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
262 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
7504 usd
CY2022Q2 us-gaap Assets
Assets
262 usd
CY2021Q4 us-gaap Assets
Assets
7504 usd
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
92849 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
81473 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
92849 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
81473 usd
CY2022Q2 us-gaap Liabilities
Liabilities
92849 usd
CY2021Q4 us-gaap Liabilities
Liabilities
81473 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
740000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
740000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
296748183 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
296748183 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
296748183 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
296748183 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
296748 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
296748 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2288255 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2288255 usd
CY2022Q2 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
119867 usd
CY2021Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
299667 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1857 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1866 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2555866 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2357439 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-92587 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-73969 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
262 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7504 usd
CY2022Q2 us-gaap Revenues
Revenues
6196 usd
CY2021Q2 us-gaap Revenues
Revenues
39864 usd
us-gaap Revenues
Revenues
81913 usd
us-gaap Revenues
Revenues
61133 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
1258 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
27374 usd
us-gaap Cost Of Revenue
CostOfRevenue
84042 usd
us-gaap Cost Of Revenue
CostOfRevenue
40265 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
4938 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
12490 usd
us-gaap Gross Profit
GrossProfit
-2129 usd
us-gaap Gross Profit
GrossProfit
20868 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8057 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
139544 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16058 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
139971 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
89900 usd
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
-0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
179800 usd
us-gaap Share Based Compensation
ShareBasedCompensation
-0 usd
CY2022Q2 TLGN Professional Income Expense
ProfessionalIncomeExpense
3 usd
CY2021Q2 TLGN Professional Income Expense
ProfessionalIncomeExpense
-1455 usd
TLGN Professional Income Expense
ProfessionalIncomeExpense
-843 usd
TLGN Professional Income Expense
ProfessionalIncomeExpense
-3775 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
97954 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
140999 usd
us-gaap Operating Expenses
OperatingExpenses
196701 usd
us-gaap Operating Expenses
OperatingExpenses
143746 usd
CY2022Q2 TLGN Sundry Income
SundryIncome
403 usd
CY2021Q2 TLGN Sundry Income
SundryIncome
954 usd
TLGN Sundry Income
SundryIncome
403 usd
TLGN Sundry Income
SundryIncome
954 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
403 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
954 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
403 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
954 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-92613 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-127555 usd
us-gaap Profit Loss
ProfitLoss
-198427 usd
us-gaap Profit Loss
ProfitLoss
-121924 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-92613 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-127555 usd
us-gaap Net Income Loss
NetIncomeLoss
-198427 usd
us-gaap Net Income Loss
NetIncomeLoss
-121924 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-18 usd
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
288 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
9 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-112 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-92631 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-127267 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-198418 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-122036 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
296748183 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220859583 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
296748183 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220859583 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
296748183 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
220859583 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
296748183 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
220859583 shares
us-gaap Net Income Loss
NetIncomeLoss
-198427 usd
us-gaap Net Income Loss
NetIncomeLoss
-121924 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
179800 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
11376 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-11716 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7251 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-133640 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
134647 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
134647 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
112 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7242 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
895 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7504 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
262 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
905 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
100263 usd
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-400 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
5631 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
105494 usd
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
288 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
11597 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-127555 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-10176 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-73969 usd
CY2022Q1 TLGN Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
89900 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
27 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-105814 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-89856 usd
CY2022Q2 TLGN Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
89900 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-18 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-92613 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-92587 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_801_eus-gaap--BasisOfAccounting_z0n9W34yNJGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 9%"><b>NOTE<span style="font-family: Times New Roman, Times, Serif">-</span>1</b></td> <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 91%"><b><span id="xdx_82D_zCrOYaDRRYqj">BASIS OF PRESENTATION</span></b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements have been prepared by management in accordance with both accounting principles generally accepted in the United States (“GAAP”), and the instructions to Rule 10-01 of Regulation S-X. Certain information and note disclosures normally included in audited financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of management, the consolidated balance sheet as of December 31, 2021 which has been derived from audited financial statements and these unaudited condensed consolidated financial statements reflect all normal and recurring adjustments considered necessary to state fairly the results for the periods presented. The results for the period ended June 30, 2022 are not necessarily indicative of the results to be expected for the entire fiscal year ending December 31, 2022 or for any future period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the Management’s Discussion and the audited financial statements and notes thereto included in the Amended Annual Report on Form 10-K for the year ended December 31, 2021, as filed on May 20, 2022.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zspPxJV0XwN9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0%"> </td> <td style="width: 5%"><span style="font-family: Wingdings; font-size: 10pt">l</span></td> <td style="text-align: justify; width: 95%"><span style="font-size: 10pt"><span id="xdx_863_zjL7UAYeGTA4">Use of estimates and assumptions</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these condensed consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the periods reported. Actual results may differ from these estimates.</p>
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
740000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
740000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
119867 usd
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
296748183 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
296748183 shares
CY2022Q2 TLGN Working Capital
WorkingCapital
92587 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-198427 usd
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
0 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
0 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
472223 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
431105 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
44854 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
44421 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
517077 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
475526 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
6196 usd
CY2021Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
39864 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
81913 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
61133 usd
CY2022Q2 TLGN Cost Paid From Related Party Debt
CostPaidFromRelatedPartyDebt
63882 usd
CY2021Q2 TLGN Cost Paid From Related Party Debt
CostPaidFromRelatedPartyDebt
0 usd
TLGN Cost Paid From Related Party Debt
CostPaidFromRelatedPartyDebt
63882 usd
TLGN Cost Paid From Related Party Debt
CostPaidFromRelatedPartyDebt
1391 usd
CY2022Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
6196 usd
CY2021Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
39864 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
61133 usd
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes

Files In Submission

Name View Source Status
0001683168-22-005953-index-headers.html Edgar Link pending
0001683168-22-005953-index.html Edgar Link pending
0001683168-22-005953.txt Edgar Link pending
0001683168-22-005953-xbrl.zip Edgar Link pending
everharvest_ex2100.htm Edgar Link pending
everharvest_ex3101.htm Edgar Link pending
everharvest_ex3102.htm Edgar Link pending
everharvest_ex3201.htm Edgar Link pending
everharvest_ex3202.htm Edgar Link pending
everharvest_i10q-063022.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlgn-20220630.xsd Edgar Link pending
tlgn-20220630_cal.xml Edgar Link unprocessable
tlgn-20220630_pre.xml Edgar Link unprocessable
everharvest_i10q-063022_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
tlgn-20220630_def.xml Edgar Link unprocessable
tlgn-20220630_lab.xml Edgar Link unprocessable